EMT in breast cancer is tightly linked to the triple negative (ER-, PR- and ErbB2-) basal-like breast cancer subgroup and cancer stem cells [6], [7], [8], [9], [10], [11], [12]. This evidence concerns the gene ESR1 and breast carcinoma.